Treatment of ventricular extrasystoles and tachyarrhythmias in acute myocardial infarction.
D000138:Acidosis / Q000517:prevention & control; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control / Q000601:surgery / Q000628:therapy; D005117:Cardiac Complexes, Premature / Q000628:therapy*; D004554:Electric Countershock; D006801:Humans; D000860:Hypoxia / Q000517:prevention & control; D008012:Lidocaine / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications*; D010138:Pacemaker, Artificial; D010672:Phenytoin / Q000627:therapeutic use; D011191:Potassium Deficiency / Q000517:prevention & control; D011433:Propranolol / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol